HIGHLIGHTS
- who: Clara Maier from the Sapienza University of Rome, Italy have published the research work: Mucosal immunization with an adenoviral vector vaccine confers superior protection against RSV compared to natural immunity, in the Journal: (JOURNAL)
- what: The authors evaluate the immunogenicity and protective efficacy of an Ad5-based mucosal vaccine encoding for RSV F (Ad-F). The data generated in this study underline that the adjuvant activities of IL-1b benefit Frontiers in Immunology frontiersin.org 10.3389/fimmu.2022.920256 increased weight loss compared to naïve animals and a relatively high tissue damage . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.